Can You Take Metronidazole and Lithium Together?

No — metronidazole and lithium should not be combined without close medical supervision and laboratory monitoring. Short-term metronidazole therapy is associated with elevation of serum lithium levels and clinical signs of lithium toxicity in patients taking lithium maintenance therapy. The FDA classifies this as a major drug interaction, meaning it carries significant risk of adverse effects and requires immediate intervention to prevent harm.

What the FDA Says

According to FDA drug labeling data sourced from over 250,000 pharmaceutical labels, metronidazole and lithium have a documented major-severity interaction. The FDA description explicitly states: "Short-term metronidazole therapy associated with elevation of serum lithium and signs of lithium toxicity in patients on high doses. Serum lithium and creatinine levels should be monitored."

This interaction is serious enough to appear in the contraindications or warnings sections of both metronidazole and lithium product labels. Clinicians are advised to avoid co-prescription when possible, and when unavoidable, to implement enhanced laboratory surveillance. The mechanism involves direct alteration of lithium clearance by the kidneys — a critical concern given lithium's narrow therapeutic window.

How This Interaction Works

Lithium is a unique psychiatric medication with a small margin between therapeutic and toxic doses. The therapeutic range for serum lithium is typically 0.5 to 1.2 mEq/L (or 0.5 to 1.0 mEq/L in some maintenance protocols). Levels above 1.5 mEq/L begin to produce toxicity symptoms; levels above 2.0 mEq/L carry risk of severe or life-threatening toxicity.

Unlike most psychiatric drugs, lithium is not metabolized by the liver. Instead, it is filtered by the kidneys and largely reabsorbed in the proximal tubules, with only about 20% excreted unchanged in urine under normal conditions. This renal handling is the critical vulnerability point.

Metronidazole, an antibiotic commonly prescribed for bacterial and parasitic infections (bacterial vaginosis, trichomoniasis, anaerobic bacterial infections, and certain protozoan infections), reduces glomerular filtration rate (GFR) and decreases renal blood flow. The exact mechanism is not fully characterized but involves acute kidney injury-like changes that reduce the kidneys' ability to clear lithium.

When metronidazole is started in a patient on stable lithium therapy, serum lithium concentrations can rise by 25–50% or more within 3–5 days. This elevation occurs because lithium excretion is impaired while renal reabsorption continues at baseline rates, leading to accumulation. Even in patients taking "high doses" (the FDA's phrasing suggests doses at the upper end of the therapeutic range), this can push serum levels into the toxic zone.

Additionally, metronidazole may cause gastrointestinal side effects (nausea, vomiting, metallic taste) that can affect lithium absorption or patient compliance, though the primary mechanism is renal.

Who Is Most at Risk

Patients at highest risk include:

• Those on high-dose lithium maintenance therapy (≥900 mg/day or serum levels already 0.8–1.2 mEq/L)
• Older adults (age ≥65) with age-related reduction in GFR, even if serum creatinine appears normal
• Patients with underlying renal disease or diabetes, hypertension, or other conditions affecting kidney function
• Those on concurrent diuretics or NSAIDs, which also reduce renal lithium clearance
• Dehydrated patients or those with volume depletion, which enhances lithium reabsorption
• Patients on ACE inhibitors or angiotensin receptor blockers, which reduce glomerular filtration

Population-level data on this interaction is sparse in published literature, but case reports and spontaneous adverse event reports to the FDA document recurring clusters of lithium toxicity cases following metronidazole initiation. The interaction is predictable and expected, not idiosyncratic, meaning most patients will experience some degree of serum lithium elevation.

Clinical Scenario 1: Bacterial Vaginosis and Bipolar Maintenance

A 52-year-old woman with bipolar I disorder has been stable on lithium 900 mg daily (divided doses) for 8 years, with recent serum lithium levels around 0.9 mEq/L and normal renal function (eGFR 68 mL/min/1.73m²). She presents to her gynecologist with symptoms of bacterial vaginosis and is prescribed metronidazole 500 mg twice daily for 7 days. Neither her gynecologist nor her psychiatrist knew about the other's prescription at the time.

By day 4 of metronidazole therapy, she develops coarse tremor in her hands, mild confusion, and nausea. Her serum lithium level is measured at 1.8 mEq/L — a 100% increase from her baseline. She is at risk for lithium-induced nephrogenic diabetes insipidus, cardiac arrhythmias, and neurotoxicity. Management requires immediate discontinuation of metronidazole, increased hydration, and possible hospitalization for renal monitoring. Her psychiatrist must determine alternative antibiotic therapy (e.g., clindamycin) and resume lithium only when kidney function recovers.

Clinical Scenario 2: Diverticulitis in an Older Adult

A 73-year-old man with treatment-resistant depression maintained on lithium 600 mg daily (serum level 0.7 mEq/L, eGFR 52 mL/min/1.73m²) develops acute diverticulitis. His primary care physician prescribes metronidazole 500 mg three times daily as part of an outpatient regimen for 10 days. The patient's serum creatinine is 1.2 mg/dL, which appears only mildly elevated for his age, masking more significant age-related renal decline.

After 5 days, his family notices increasing confusion, unsteadiness, and a coarse tremor. He falls once at home. Serum lithium is found to be 1.6 mEq/L; serum creatinine has risen to 1.5 mg/dL, indicating acute kidney injury from metronidazole. He requires hospitalization for intravenous hydration, lithium discontinuation, and monitoring until kidney function recovers. This case illustrates how even "moderate" doses of lithium carry risk in older adults with reduced renal reserve, and how age-related physiological changes mask true renal dysfunction.

What to Do: Management Guidance

If you are on lithium and need an antibiotic:

1. Tell your doctor immediately that you take lithium. Provide a complete list of all your medications.
2. Ask specifically about this interaction. Do not assume your doctor will catch it automatically.
3. Explore alternatives first. Metronidazole alternatives include clindamycin (for most anaerobic bacteria and protozoal infections), fluoroquinolones (for certain gram-negatives and some anaerobes), or azithromycin. Not all infections can be treated with every antibiotic, but your prescriber should consider this interaction when choosing.
4. If metronidazole is absolutely necessary, your doctor should:
   • Reduce your lithium dose by 25–50% or temporarily discontinue it
   • Order a serum lithium level before starting metronidazole and again on day 3–5 of metronidazole therapy
   • Check serum creatinine to assess kidney function
   • Ensure you drink adequate water (2–3 liters per day) to support renal blood flow
   • Schedule a follow-up level 5–7 days after stopping metronidazole to guide lithium dose reinstatement
5. Do not stop lithium on your own. Abrupt discontinuation of lithium in bipolar disorder increases relapse risk substantially within days to weeks.

If you are on metronidazole and take lithium:

1. Do not stop metronidazole abruptly without medical guidance. Premature discontinuation of antibiotics can allow infection to rebound or develop antibiotic resistance.
2. Watch for early signs of lithium toxicity (see next section) and report them immediately.
3. Stay well-hydrated. Dehydration worsens lithium reabsorption and toxicity risk.
4. Avoid NSAIDs (ibuprofen, naproxen) while on this combination, as they further reduce lithium clearance.
5. Keep all lab appointments your doctor schedules. Do not reschedule or skip them.

When to Call Your Doctor or Pharmacist

Seek immediate medical attention if you experience any of the following while on metronidazole and lithium:

• Coarse hand tremor or tremor that worsens over hours
• Confusion, disorientation, or difficulty concentrating
• Severe nausea, vomiting, or diarrhea
• Muscle weakness, stiffness, or rigidity
• Loss of coordination or ataxia (unsteady gait)
• Irregular or rapid heartbeat (palpitations)
• Excessive thirst or urination
• Slurred speech or slowed movements
• Seizures or loss of consciousness
• Fever or signs of infection worsening despite antibiotics

These are signs of lithium toxicity or serious adverse effects. Go to an emergency department or call 911 if symptoms are severe. For less acute concerns (mild tremor, mild confusion), call your prescriber or pharmacist the same day.

Key Takeaways

• Metronidazole and lithium is an FDA major-severity interaction. Metronidazole reduces renal lithium clearance, causing serum levels to rise 25–50% or more within days, risking toxicity.
• Alternative antibiotics exist for most infections. Discuss alternatives with your doctor first; metronidazole should be used only if no substitute is available.
• If metronidazole is essential, enhanced monitoring is mandatory: baseline serum lithium level, levels on days 3–5 of therapy, and serum creatinine. Lithium dose reduction is typically needed.
• Older adults and patients with reduced renal function are at highest risk. Age-related kidney decline may be underestimated by serum creatinine alone; eGFR is more reliable.
• Never stop lithium abruptly. Work with your psychiatrist or prescriber to coordinate antibiotic therapy, lithium dosing, and lab monitoring safely.

Sources

• FDA Drug Labeling via OpenFDA: https://open.fda.gov/ (metronidazole and lithium product labels)
• National Institutes of Health, National Library of Medicine Drug Information: https://www.nlm.nih.gov/medlineplus/
• Lithium Official FDA Label: Interaction warnings and monitoring guidance
• Metronidazole Official FDA Label: Known drug interactions
• American Psychiatric Association: Lithium Monitoring Recommendations

Do you take both metronidazole and lithium or suspect a drug interaction with your medications? Check the metronidazole and lithium interaction in our comprehensive database. You can also search your entire medication list at checkdruginteractions.com — the most trusted, FDA-powered drug interaction checker online. Enter all your medications, supplements, and over-the-counter drugs to get a complete picture of potential interactions before they cause harm. Your pharmacy team can also run this check, but having your own verified record ensures nothing is missed.